ONYX logo

ONYX Biotec Limited

ONYX·NSE·
41.00 +0.00 (+0.00%)
Market Cap76.25 Cr
PE Ratio15.02
Volume50,000
Day High - Low41.00 - 41.00
52W High-Low51.00 - 24.20
DocStoX Score
5.5/10
Fair
Fair Value
Sign in to see
ROE
-0.38%
Weak
P/E
15.02x
Fair
Debt / Equity
0.27
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

52W24.20
51.00
DocStoX take

Supported by growth (7.5) and momentum (6.8), but held back by quality (2.9). Growth looks strong at 7.5, but that is offset by quality at 2.9. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.5
/10
Fair
Quality
Weak
ROE -0.4%
Valuation
Fair
P/E 15.0×
Growth
Strong
Revenue +20.7% 3Y CAGR
Risk
Moderate
D/E 0.27
Momentum
Firm
63% of 52-week range

At a glance

Market Cap
₹76 Cr
52W High / Low
₹51 / ₹24
Dividend Yield
0.00%
Promoter Holding
65.10%
EPS (TTM)
₹2.73
Book Value
₹30.56

Key highlights

  • Revenue compounding 21% a year
  • Small ₹76 cr company — thinner liquidity
1 Positive1 Watchout

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

ONYX BIOTEC LIMITED peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.